Hyperhomocysteinemia activates NF-κB and inducible nitric oxide synthase in the kidney

Kidney International

Volumn 65, Issue 4, 2004, Pages 1327-1338

  Zhang, Fan ^b   Siow, Yaw L ^b   Karmin, O ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Homocysteine; Inducible nitric oxide synthase; Nuclear factor B; Peroxynitrite

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHIONINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HYPERHOMOCYSTEINEMIA; KIDNEY; KIDNEY DISEASE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 1642504386     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00510.x     Document Type: Article

References (41)

1. MCCULLY KS: Homocyst(e)ine and vascular disease. Nat Med 2:386-389, 1996
2. CLARKE R, DALY L, ROBINSON K, et al: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
3. DUELL PB, MALINOW MR: Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 8:28-34, 1997
4. REFSUM H, UELAND PM, NYGARD O, VOLLSET SE: Homocysteine and cardiovascular disease. Ann Rev Med 49:31-62, 1998
5. HARKER LA, SLICHTER SJ, SCOTT CR, Ross R: Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 291:537-543, 1974
6. WHEELER DC: Cardiovascular disease in patients with chronic renal failure. Lancet 348:1673-1674, 1996
7. WEISS N, HEYDRICK S, ZHANG YY, et al: Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22:34-41, 2002
8. TSAI JC, PERRELLA MA, YOSHIZUMI M, et al: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-6373, 1994
9. CHEN C, HALKOS ME, SUROWIEC SM, et al: Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res 88:26-33, 2000
10. DURAND P, LUSSIER-CACAN S, BLACHE D: Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11:1157-1168, 1997
11. O K, LYNN EG, CHUNG YH, et al: Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta 1393:317-324, 1998
12. WERSTUCK GH, LENTZ SR, DAYAL S, et al: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107:1263-1273, 2001
13. MCCULLY KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128, 1969
14. KUMAGAI H, KATOH S, HIROSAWA K, et al: Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int 62:1219-1228, 2002
15. LI N, CHEN Y, ZOU AP: Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 39:443-448, 2002
16. BAEUERLE PA: IκB-NF-κB structures: At the interface of inflammation control. Cell 95:729-731, 1998
17. BRAND K, PAGE S, ROGLER G, et al: Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97:1715-1722, 1996
18. WILSON SH, CAPLICE NM, SIMARI RD, et al: Activated nuclear factor-κB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 148:23-30, 2000
19. COLLINS T, CYBULSKY MI: NF-κB: Pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255-264, 2001
20. SUNG FL, ZHU TY, AU-YEUNG KKW, et al: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-κB. Kidney Int 62:1160-1170, 2002
21. SIMEONIDIS S, STAUBER D, CHEN G, et al: Mechanisms by which IkappaB proteins control NF-kappaB activity. Proc Natl Acad Sci USA 96:49-54, 1999
22. THURBERG BL, COLLINS T: The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 9:387-396, 1998
23. WOO CWH, CHEUNG F, CHAN VWH, et al: Homocysteine stimulates iNOS expression in macrophages: Antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem 243:37-47, 2003
24. NAPOLI C, IGNARRO LJ: Nitric oxide and atherosclerosis. Nitric Oxide 5:88-97, 2001
25. MASTERS BS, MARTÁSEK P, ROMAN LJ: Structural variations on a theme of nitric oxide production by three isoforms of nitric oxide synthase, in Pathophysiology and Clinical Applications of Nitric Oxide, edited by Rubanyi GM, Amsterdam, Harwood Academic, 1999, pp 17-37
26. LI H, FÖRSTERMANN U: Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254, 2000
27. LIEBERTHAL W: Biology of ischemic and toxic renal tubular injury: Role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 7:289-295, 1998
28. CHATTERJEE PK, PATEL NS, KVALE EO, et al: Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 91:862-871, 2002
29. MARKEWITZ BA, MICHAEL JR, KOHAN DE: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 61:2138-2143, 1993
30. FISCHER PA, DOMINGUEZ GN, CUNIBERTI LA, et al: Hyperhomocysteinemia induces renal hemodynamic dysfunction: Is nitric oxide involved? J Am Soc Nephrol 14:653-660, 2003
31. HUIE RE, PADMAJA S: The reaction of NO with superoxide. Free Radic Res Commun 18:195-199, 1993
32. WANG G, WOO CWH, SUNG FL, et al: Increased monocyte adhesion to aortic endothelium in rat with hyperhomocysteinemia: Role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 22:1777-1783, 2002
33. CHEUNG F, SIOW YL, O K: Ginkgolides and bilobalide affect the production of nitric oxide in THP-1 macrophages but not in endothelial cells. Biochem Pharmacol 61:503-510, 2001
34. WANG G, SIOW YL, O K: Homocysteine stimulates nuclear factor-κB activity and monocyte chemoattractant protein-1 expression in vascular smooth muscle cells: A possible role of protein kinase C. Biochem J 352:817-826, 2000
35. WANG G, SIOW YL, O K: Homocysteine-induced monocytes chemoattractant protein-1 expression in human monocytic cells is mediated by nuclear factor-κB activation. Am J Physiol 280:H2840-H2847, 2001
36. DAVIS KL, MARTIN E, TURKO IV, MURAD F: Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236, 2001
37. WINK DA, MITCHELL JB: Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25:434-456, 1998
38. ROMAGNANI P, PUPILLI C, LASAGNI L, et al: Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol 187:345-350, 1999
39. GOLIGORSKY MS, BRODSKY SV, NOIRI E: Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61:855-861, 2002
40. BUTTERY LD, SPRINGALL DR, CHESTER AH, et al: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75:77-85, 1996
41. MACMILLAN-CROW LA, CROW JP, KERBY JD, et al: Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93:11853-11858, 1996